HALO logo
halo search icon
Rezolute, Inc.

US$3.22

Price Change Indicator
0.12 (3.87%)
Rezolute, Inc.
RZLT · NAS

Rezolute, Inc.

Start Trading RZLT for Free

US$3.22

Price Arrow0.12 (3.87%)
20/05/2026 04:00:00 PM
All-CompaniesAll-ConsensusHALO AllHALO Earnings MomentumRecent Earnings upgrade
Consensus Score
Lock Icon/10
Recommend
Lock
Target Price
Lock
Deviation
Lock
Unlock Full Consensus Insights

Rezolute, Inc. Overview

RZLT Health Scores

Short Term

Mean Reversion

Neutral

Trend

Neutral

Event

Neutral

HALO Model

Mqv

Very Weak

Garp

Very Weak

Mqv Small

Neutral

Valuation

Value

Lock Icon

Consensus

Lock Icon

Momentum

Price

Weak

Earnings

Very Strong

Growth

Earnings

Strong

Dividends

Very Weak

Quality

Capital Efficiency

Very Weak

Balance Sheet

Very Weak

About RZLT

icon
icon

Telephone

1.650.206.4507

icon

Address

500 Suite, 275 Shoreline Drive, Redwood City, CA 94065

Description

Rezolute, Inc. operates as a biopharmaceutical company, which engages in the development of drug therapies for patients with metabolic and orphan diseases. The firm's antibody therapy, ersodetug, is designed to treat all forms of hyperinsulinism. The company was founded by Nevan Charles Elam, Ho Young Huh, and Sankaram Mantripragada in March 2010 and is headquartered in Redwood City, CA.

RZLT Price Chart

Key Stats

Market Cap

US$298.51M

PE

0.00

EV/EBITDA

N/A

Dividends Overview

DIV Yield

0%

Franking

0%

Ex Dividend Date (est.)

N/A

Market Data

52 weeks range

Low 1.07 - 11.46

Trade Value (12mth)

US$2,656,565.00

1 week

-7.19%

1 month

-5.49%

YTD

43.19%

1 year

-22.69%

All time high

750.00

Key Fundamentals

EPS 3 yr Growth

-56.60%

EBITDA Margin

0.00%

Operating Cashflow

-$69m

Free Cash Flow Return

-48.30%

ROIC

-52.10%

Interest Coverage

0.00

Quick Ratio

14.40

Other Data

Shares Outstanding (Fully Diluted)

104m

HALO Sector

Healthcare

Next Company Report Date

10-Sep-26

Next Ex Dividend Date

N/A

Next Dividend Pay Date

N/A

Reporting Currency

USD

Short Sell (% of issue)

0.00

RZLT Announcements

Latest Announcements

DateAnnouncements
13 May 26
13 May 26
13 May 26
13 May 26
05 May 26

RZLT Fundamentals

Per Share Records

Historical data

Forecast data

USD2021202220232024202320242025202620272028
Per Share, Growth & Valuations
EPS (Basic)
 $locklocklocklock-1.01-1.33-0.98locklocklock
EPS (Fully Diluted)
 $locklocklocklock-1.01-1.33-0.98locklocklock
Growth
 %locklocklocklock55.2-31.526.4locklocklock
PE
 XlocklocklocklockN/AN/AN/Alocklocklock
EV/EBITDA
 XlocklocklocklockN/AN/AN/Alocklocklock

Dividends

Key Stats

Ex Dividend Date (est.)

N/A

DIV Yield

0%

Franking Level

0%

DPSg

N/A

Quality Yield

lock

Falling Divs over next 2

lock

Want to learn more?Frequently asked questions.
What is the current share price of Rezolute, Inc. (RZLT:NAS)?
Halo FAQ
The current share price of Rezolute, Inc. (RZLT:NAS) is USD$3.22.
What is the 52-week high share price for Rezolute, Inc. (RZLT:NAS)?
Halo FAQ
The 52-week high share price for Rezolute, Inc. (RZLT:NAS) is USD$11.46.
What is the 52-week low share price for Rezolute, Inc. (RZLT:NAS)?
Halo FAQ
The 52-week low share price for Rezolute, Inc. (RZLT:NAS) is USD$1.07.
What is the dividend yield for Rezolute, Inc. (RZLT:NAS)?
Halo FAQ
Rezolute, Inc. (RZLT:NAS) does not pay a dividend.
What was Rezolute, Inc. (RZLT:NAS) last dividend payment?
Halo FAQ
Rezolute, Inc. (RZLT:NAS) does not pay a dividend.
What is the franking level for Rezolute, Inc. (RZLT:NAS)?
Halo FAQ
Rezolute, Inc. (RZLT:NAS) has a franking level of 0.00%.
In which sector is Rezolute, Inc. (RZLT:NAS) classified?
Halo FAQ
Rezolute, Inc. (RZLT:NAS) is classified in the Healthcare.

See beyond the curve.

One solution for research, investing and portfolio management.
Start FREE Trial